Real-Time Bioanalysis Services for Cellular Kinetic (CK)

Online Inquiry

Background Service Service Packages Workflow Highlights FAQs Contact

The development of advanced cell therapies is often constrained by the challenge of accurately characterizing the dynamic in vivo behavior of these "living drugs." Creative Biolabs' Real-Time Bioanalysis Services for Cellular Kinetics (CK) provide a robust, dual-platform solution to this critical need. Our service integrates high-sensitivity molecular and phenotypic analyses to deliver real-time, longitudinal data on cellular expansion, persistence, and systemic response. This approach provides sponsors with essential insights into pharmacokinetics and safety, de-risking clinical development and accelerating the path to regulatory approval.

Introduction

CAR-T cell therapy has demonstrated remarkable success in treating hematological malignancies, shifting the treatment paradigm. However, the "living drug" nature of CAR-T cells results in highly dynamic and multiphasic in vivo kinetics, encompassing distribution, expansion, contraction, and persistence phases, that exhibit significant interpatient variability. Thus, it is important to elucidate the key cellular kinetic parameters that govern treatment response and identify potential predictive biomarkers for long-term remission.

Fig.1 Multistage CAR-T cell kinetics. (OA Literature) Fig.1 Kinetic profile of CAR-T cell phases.¹

Real-Time Bioanalysis Services for Cellular Kinetic (CK) at Creative Biolabs

Creative Biolabs delivers a sophisticated bioanalytical platform engineered to profile the complete cellular kinetic lifecycle. Our approach integrates molecular and phenotypic data, generating high-fidelity, audit-compliant datasets that support global regulatory submissions. We offer tailored solutions to navigate analytical challenges, providing critical insights into the safety and efficacy profiles of advanced cell therapies.

Service Packages

Our Real-Time Bioanalysis Services for Cellular Kinetics provide two core analytical pillars essential for modern cell therapy development. These integrated services deliver critical insights from complementary perspectives, covering both the fate of the therapeutic cells and the patient's systemic immune response.

CAR-T Persistence Bioanalysis Service

This service enables precise, longitudinal tracking of cellular therapy kinetics. By integrating immediate molecular (PCR) and phenotypic (Flow Cytometry) analyses, we deliver real-time data on CAR-T cell expansion, persistence, and phenotypic evolution in patient samples. It directly supports pharmacokinetic (PK) profiling, dose-response correlation, and the assessment of long-term therapeutic activity, which are critical for clinical development and regulatory filings.

Cytokine & Biomarker Profiling Service

We provide real-time, multiplexed analysis of key serum biomarkers (e.g., IL-6, ferritin, CRP) to monitor the systemic pharmacodynamic (PD) response to cell therapies. This profiling is essential for early detection and mechanistic understanding of adverse events like CRS and neurotoxicity, enabling proactive patient management, correlating safety with cellular kinetics, and supporting comprehensive risk assessment in clinical trials.

Our Service Process

Required Starting Materials:

Transgene Sequence Information: The specific CAR/TCR construct sequence for primer/probe design (ddPCR).
Target Cell Phenotype Data: Baseline flow cytometry panels used during manufacturing.
Project Scope: Estimated sample volume and desired clinical/preclinical time points.

Key Steps:

Workflow of real-time bioanalysis services for CK at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Comprehensive Bioanalytical Report: Detailed PK parameters.
Raw Data & Gating Strategies: Complete flow cytometry files and ddPCR droplet plots.

Key Advantages

Tailored Analytical Systems: We develop fully customized analytical solutions engineered exclusively for your unique therapeutic constructs and delivery vectors.
High-Throughput Expertise: Leveraging fully automated DNA extraction and high-density digital PCR arrays, we support the processing of over 100,000 samples while maintaining rapid turnaround times.
Advanced Genomic Analysis: Through integrated codon optimization analysis and rigorous quality control methodologies, we deliver precise quantification and characterization of integrated genetic material in both batch and continuous clinical monitoring workflows.

FAQs

Q1: Is whole blood or isolated PBMC more suitable for CK analysis?

A1: While either sample type is acceptable, our validation studies demonstrate that performing ddPCR directly on whole blood achieves comparable analytical performance while streamlining sample collection, processing, and stability requirements.

Q2: How do you address the "Normalization Paradox" in samples with very high cell expansion?

A2: To ensure data integrity across all phases of cellular kinetics, we employ a dual-metric reporting strategy. Results are quantified both as copies per microgram of gDNA and as copies per microliter of whole blood, providing accurate insights even during peak expansion periods.

Q3: Does your service accommodate inducible or switchable CAR-T system designs?

A3: Yes. Our platform is specifically designed to provide synchronized pharmacokinetic monitoring, enabling co-analysis of the cellular therapy's kinetics alongside the pharmacokinetics of its small-molecule inducer or switch controller.

Why Choose Us?

Choose Creative Biolabs for our unique biological insight and advanced technical capabilities. We treat cells as dynamic systems, operating specialized platforms for complex CAR designs. We deliver superior analytical sensitivity, validated against published benchmarks, to detect ultra-low persistence levels other CROs may miss, ensuring robust, reliable data for your pivotal decisions.

How to contact us?

To unlock unparalleled insights into your cell therapy's behavior, contact us. We transform complex cellular kinetic challenges into actionable, high-fidelity data. Let's discuss how our tailored, real-time bioanalysis can de-risk and accelerate your program. Reach out today for a dedicated project consultation and a custom proposal.

Reference

Paixão, Emanuelle A et al. "Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation." Cancers vol. 14,22 5576. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3390/cancers14225576

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.